How Drug Brands Stopped Off-Label Use and Stayed on the Market
How drug brands fought off-label prescribing to survive: real FDA cases, litigation wins, and what AI monitoring means for pharmacovigilance […]
Everything Is Off-Label Now
A quiet tour through how drugs escape their instructions—and what that says about modern demand There’s a peculiar irony in
When Drugs Misbehave (and When They Don’t)
Side effects, safety signals, and the uncomfortable gap between “works” and “well tolerated” Drug development has a habit of looking
When AI Cites Reddit Instead of the Your Drug Label: The Drug Information Crisis Pharma Can’t Ignore
A patient types a question into ChatGPT: “Can I take metformin and ibuprofen together?” The AI answers in seconds —
AI Monitoring Is Now Pharma’s Best Early Warning System — Here’s How to Use It
Before a drug problem reaches the FDA, it travels through the internet. A cluster of patient forum posts. A Reddit
Why Investor Relations Teams Need AI Drug Monitoring — Before the Next Earnings Call
Pharmaceutical investor relations has always operated in a world where information asymmetry matters. Management knows more than analysts. Analysts know
The Prescription Pause: Why Millions of Patients Stall at the Last Second Before Starting a Drug
There’s a moment that happens between the prescription and the first dose that pharmaceutical companies rarely talk about. Not non-adherence.
The Internet’s Favorite Pharmacy Cage Match: Ozempic vs. Mounjaro, Humira vs. Enbrel, Advil vs. Everything
There’s a particular genre of medical question that never seems to die online: not “What does this drug do?” but
The real reasons behind the internet’s most common “Why did I get moved from X to Y?” drug questions
Spend enough time reading patient forums and one theme appears over and over again: confusion bordering on suspicion. A medication
Rare Disease Drugs and LLM Accuracy: What AI Gets Wrong and Why It Matters More Than You Think
Rare disease patients are not a niche pharmaceutical concern. They are approximately 300 million people worldwide, carrying diagnoses so uncommon
When AI Gets Contraindications Wrong: The Pharma Brand and Safety Risk No One Is Tracking
ChatGPT, Gemini, and Claude now field millions of drug-safety questions every day. None of them have a medical license. Here’s
Real-Time AI Surveillance for Pharma: What Your Drug Is Saying in ChatGPT Right Now
Somewhere right now, a patient is asking ChatGPT whether their cancer drug will extend their life. A caregiver is asking